Upstate Active Clinical Trials
Study Title:A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus
What is the purpose of the study?• Whether Baricitinib combined with standard therapy can help patients with SLE.
• The safety of Baricitinib and any side effects you might have when you take it.
Upstate Institutional Review Board (IRB) Number:1400189
Patient Age Group:Adults
Principal Investigator:Andras Perl, MD, PhD
Who can I contact for more information?
Name: Joanne M Chilton, CCRP